
"Sector" = median of Real Estate across 61 companies
Alexandria Real Estate Equities (ARE) is a real estate investment trust (REIT) that focuses on owning, operating, and developing collaborative life science and technology campuses. The company's properties are primarily located in key innovation clusters across the United States, including Boston, San Francisco, New York, and San Diego. ARE is known for its high-quality, Class A office and lab space designed to foster research and development activities.
ARE generates revenue primarily through leasing its properties to tenants under long-term leases. The company's revenue is derived from base rents, tenant recoveries, and parking income. Its business model emphasizes strategic property development and redevelopment to meet the specific needs of life science and tech tenants, which often require specialized lab and office configurations. The company also benefits from a diversified tenant base and a focus on high-barrier-to-entry markets.
The REIT operates within the office and life science real estate sector, competing with other specialized REITs such as Boston Properties and Kilroy Realty. ARE differentiates itself through its exclusive focus on life science and tech clusters, which have strong demand drivers from ongoing innovation and funding in biotechnology and pharmaceuticals. The company's properties are often located near top-tier research institutions, providing a competitive edge in attracting and retaining tenants.
ARE's primary customers are leading life science companies, academic institutions, and technology firms engaged in research and development. Key markets include the San Francisco Bay Area, Boston/Cambridge, New York City, San Diego, and other innovation hubs. The company's tenant base includes both large multinational corporations and emerging startups, with a significant portion of revenue coming from investment-grade tenants.
An auto-generated descriptive profile based on company data, for informational purposes only.
No 24-hour summary has been generated yet.
Latest saved period: March 2026 · 2026-03-31
Cash dividends by ex-date, not an investment recommendation.
| Ex-date | Amount | Payment date | Period |
|---|---|---|---|
| Mar 31, 2026 | $0.72 | Apr 15, 2026 | Quarterly |
| Dec 31, 2025 | $0.72 | Jan 15, 2026 | Quarterly |
| Sep 30, 2025 | $1.32 | Oct 15, 2025 | Quarterly |
| Jun 30, 2025 | $1.32 | Jul 15, 2025 | Quarterly |
| Mar 31, 2025 | $1.32 | Apr 15, 2025 | Quarterly |
| Dec 31, 2024 | $1.32 | Jan 15, 2025 | Quarterly |
| Sep 30, 2024 | $1.30 | Oct 15, 2024 | Quarterly |
| Jun 28, 2024 | $1.30 | Jul 15, 2024 | Quarterly |
| Mar 27, 2024 | $1.27 | Apr 15, 2024 | Quarterly |
| Dec 28, 2023 | $1.27 | Jan 12, 2024 | Quarterly |
| Sep 28, 2023 | $1.24 | Oct 13, 2023 | Quarterly |
| Jun 29, 2023 | $1.24 | Jul 14, 2023 | Quarterly |
| Mar 30, 2023 | $1.21 | Apr 14, 2023 | Quarterly |
| Dec 29, 2022 | $1.21 | Jan 13, 2023 | Quarterly |
| Sep 29, 2022 | $1.18 | Oct 14, 2022 | Quarterly |
| Jun 29, 2022 | $1.18 | Jul 15, 2022 | Quarterly |
| Mar 30, 2022 | $1.15 | Apr 15, 2022 | Quarterly |
| Dec 30, 2021 | $1.15 | Jan 14, 2022 | Quarterly |
| Sep 29, 2021 | $1.12 | Oct 15, 2021 | Quarterly |
| Jun 29, 2021 | $1.12 | Jul 15, 2021 | Quarterly |
| Mar 30, 2021 | $1.09 | Apr 15, 2021 | Quarterly |
| Dec 30, 2020 | $1.09 | Jan 15, 2021 | Quarterly |
| Sep 29, 2020 | $1.06 | Oct 15, 2020 | Quarterly |
| Jun 29, 2020 | $1.06 | Jul 15, 2020 | Quarterly |
Wrqti brings Alexandria Real Estate Equities data into one page covering available price, financial statements, valuation ratios, margins, cash-flow metrics, news, and alerts. This page helps you understand the numbers and is not a buy or sell recommendation.
Companies in the Real Estate sector you can compare with Alexandria Real Estate Equities:
Compare Alexandria Real Estate Equities head-to-head with:
When available, the page shows quarterly and annual statements plus ratios such as PE, price to book, profit margin, and free cash flow. Latest financial period shown: March 2026.
Wrqti content depends on available data and third-party sources and may include delays or errors. Review official company filings and consult a licensed financial advisor before making investment decisions. Read the data methodology.